What anti-emetics are safe for use during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safe Anti-Emetics for Pregnancy

Ondansetron, metoclopramide, and certain steroids are considered safe and effective for treating nausea and vomiting during pregnancy, with metoclopramide and ondansetron being first-line options after non-pharmacological approaches. 1

First-Line Approaches

Non-Pharmacological Options

  • Diet and lifestyle modifications:
    • Small, frequent, bland meals
    • BRAT diet (bananas, rice, applesauce, toast)
    • High-protein, low-fat meals
    • Avoiding spicy, fatty, acidic, and fried foods
    • Identifying and avoiding specific triggers 1

First-Line Pharmacological Options

  1. Vitamin B6 (Pyridoxine)

    • Dosage: 10-25 mg every 8 hours 1
    • Safe and effective for mild nausea
  2. Ginger

    • Dosage: 250 mg capsule 4 times daily 1
    • Natural option with good safety profile
  3. H1-Receptor Antagonists

    • Doxylamine: FDA-approved for pregnancy nausea
    • Combination of doxylamine and pyridoxine (10 mg/10 mg or 20 mg/20 mg)
    • Promethazine and dimenhydrinate also considered safe 1
  4. Metoclopramide

    • Dosage: 5-10 mg orally every 6-8 hours
    • Meta-analysis of 33,000 first-trimester exposures showed no significant increase in congenital defects (OR 1.14,99% CI 0.93-1.38) 1
    • Should be used as second-line therapy due to risk of extrapyramidal effects 2

Second-Line Options

  1. Ondansetron

    • Safe and effective for moderate to severe nausea/vomiting
    • Small increased risk of orofacial clefts (0.03% absolute increase) and ventricular septal defects (0.3% absolute increase) 1
    • Benefits often outweigh risks in moderate-severe cases 2
    • FDA pregnancy data: "Available postmarketing data have not identified a drug associated risk of miscarriage or adverse maternal outcomes" 3
  2. Corticosteroids

    • Safe after 10 weeks of gestation (palate formation complete)
    • Preferred options: methylprednisolone or prednisolone (metabolized in placenta)
    • Avoid betamethasone or dexamethasone (nearly 100% placental passage) 1
    • Increased risk of oral clefts if used before 10 weeks gestation 1

Treatment Algorithm Based on Severity

Mild Nausea and Vomiting (PUQE score ≤6)

  1. Start with non-pharmacological approaches
  2. Add vitamin B6 (pyridoxine) and/or ginger
  3. If ineffective, add doxylamine (alone or in combination with pyridoxine)

Moderate Nausea and Vomiting (PUQE score 7-12)

  1. Combination of doxylamine and pyridoxine
  2. If ineffective, add metoclopramide
  3. Consider ondansetron if above treatments fail

Severe Nausea and Vomiting/Hyperemesis Gravidarum (PUQE score ≥13)

  1. May require IV hydration (0.9% NaCl with potassium chloride) 2
  2. Ondansetron 8 mg every 4-6 hours
  3. Consider methylprednisolone or prednisolone (after 10 weeks)
  4. Thiamine supplementation (100 mg three times daily) for women with prolonged vomiting 2

Important Considerations and Cautions

  • Combination therapy may be needed for refractory cases
  • Monitor for adverse effects and discontinue medication if they occur
  • Neurokinin-1 antagonists (aprepitant): Limited human data, FDA pregnancy class B, but avoid injection formulation (contains ethanol) 1
  • Second-generation antipsychotics (olanzapine): Linked to increased risk of ventricular and septal defects 1
  • Early intervention is key to prevent progression to hyperemesis gravidarum 1

The safety of anti-emetics in pregnancy should be balanced against the risks of untreated severe nausea and vomiting, which can lead to dehydration, weight loss, electrolyte imbalances, and poor maternal and fetal outcomes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69).

BJOG : an international journal of obstetrics and gynaecology, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.